- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/85 - Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Patent holdings for IPC class C12N 15/85
Total number of patents in this class: 10811
10-year publication summary
584
|
630
|
764
|
1014
|
1013
|
885
|
1002
|
1027
|
1042
|
567
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Regeneron Pharmaceuticals, Inc. | 4252 |
372 |
The Regents of the University of California | 19887 |
213 |
Massachusetts Institute of Technology | 10041 |
154 |
The Trustees of the University of Pennsylvania | 4317 |
143 |
President and Fellows of Harvard College | 5972 |
135 |
The Broad Institute, Inc. | 1800 |
96 |
The Board of Trustees of the Leland Stanford Junior University | 6403 |
94 |
Sangamo Therapeutics, Inc. | 415 |
75 |
Kymab Limited | 250 |
63 |
Biocytogen Pharmaceuticals (Beijing) Co., Ltd | 177 |
59 |
The General Hospital Corporation | 4724 |
58 |
The Johns Hopkins University | 5662 |
57 |
University of Massachusetts | 2224 |
56 |
Duke University | 3065 |
54 |
Modernatx, Inc. | 1259 |
52 |
Novartis AG | 10856 |
51 |
Board of Regents, The University of Texas System | 5782 |
49 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2847 |
47 |
Yale University | 2376 |
45 |
Memorial Sloan-Kettering Cancer Center | 1925 |
41 |
Other owners | 8897 |